Ishida, Hiroaki
Nakamura, Michio http://orcid.org/0000-0002-6606-1872
Komaba, Hirotaka
Uehara, Saeko
Takiguchi, Shinya
Fukagawa, Masafumi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP 25461962)
Kidney Foundation, Japan (JKFB18-29)
Article History
Received: 17 December 2020
Accepted: 8 July 2021
First Online: 17 July 2021
Declarations
:
: Dr. Nakamura received grant support from Astellas Pharma and Novartis. Dr. Komaba has received honoraria, consulting fees, and/or grant support from Bayer Yakuhin, Chugai Pharmaceutical, Japan Tobacco, Kyowa Kirin, Novartis, and Ono Pharmaceutical. Dr. Fukagawa has received honoraria, consulting fees, and/or grant support from Bayer Yakuhin, Chugai Pharmaceutical, Fresenius Kabi, Kissei Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, and Torii Pharmaceutical. The remaining authors declare no competing interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted (IRB approval number 13R015) and with the 1964 Helsinki declaration and its later amendments of comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.